Jinhe Biotechnology CO., LTD. (002688.SZ)
CNY 4.85
(4.08%)
CNY 4.85
(4.08%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.17 Billion | 2.12 Billion | 2.07 Billion | 1.81 Billion | 1.78 Billion | 1.62 Billion |
| Cost of Revenue | 1.57 Billion | 1.5 Billion | 1.42 Billion | 1.18 Billion | 1.12 Billion | 1.01 Billion |
| Gross Profit | 602.51 Million | 613.79 Million | 651.06 Million | 629.94 Million | 653.12 Million | 616.32 Million |
| Operating Expenses | 497.77 Million | 441.76 Million | 420.13 Million | 398.65 Million | 396.03 Million | 366.11 Million |
| Selling, General and Administrative Expenses | 227.41 Million | 188.47 Million | 179.81 Million | 172.47 Million | 182.08 Million | 189.99 Million |
| Research and Development Expenses | 96.64 Million | 82.28 Million | 72.25 Million | 66.35 Million | 60.7 Million | 40.51 Million |
| Other Expenses | 173.71 Million | 171 Million | 168.07 Million | 159.81 Million | 153.24 Million | 135.6 Million |
| Cost and Expenses | 2.06 Billion | 1.95 Billion | 1.84 Billion | 1.58 Billion | 1.52 Billion | 1.37 Billion |
| Operating Income | 104.73 Million | 205.02 Million | 225.51 Million | 218.18 Million | 318.86 Million | 271.84 Million |
| Interest Expense | 60.17 Million | 46.56 Million | 56.26 Million | 60.34 Million | 61.31 Million | 50.06 Million |
| Income Tax Expense | 7.06 Million | 804.27 Thousand | 20.82 Million | 1.71 Million | 29.87 Million | 30.11 Million |
| Earnings before Tax | 101.49 Million | 118.84 Million | 142.91 Million | 140.9 Million | 220.2 Million | 194.51 Million |
| Net Income | 86.45 Million | 118.04 Million | 93.99 Million | 117.32 Million | 184.93 Million | 163.62 Million |
| Earnings Per Share Basic | 0.11 | 0.15 | 0.14 | 0.18 | 0.29 | 0.26 |
| Earnings Per Share Diluted | 0.11 | 0.15 | 0.14 | 0.18 | 0.29 | 0.26 |
| Weighted Average Shares Outstanding | 780.29 Million | 780.4 Million | 671.37 Million | 635.28 Million | 635.28 Million | 629.34 Million |
| Weighted Average Shares Outstanding (Diluted) | 780.29 Million | 780.4 Million | 671.37 Million | 635.28 Million | 635.28 Million | 629.34 Million |
| Gross Margin | 0.28 | 0.29 | 0.31 | 0.35 | 0.37 | 0.38 |
| EBIT Margin | 0.16 | 0.17 | 0.17 | 0.19 | 0.23 | 0.22 |
| Profit Margin | 0.04 | 0.06 | 0.05 | 0.06 | 0.10 | 0.10 |
| EBITDA | 345.42 Million | 284.6 Million | 357.58 Million | 326.9 Million | 380.96 Million | 330.91 Million |
| Earnings Before Tax Margin | 0.05 | 0.10 | 0.11 | 0.12 | 0.18 | 0.17 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 591.52 Million | 546.29 Million | 519.45 Million | 604.28 Million | 2.17 Billion | 537.36 Million |
| Cost of Revenue | 395.11 Million | 368.93 Million | 341.88 Million | 449.95 Million | 1.53 Billion | 357.75 Million |
| Gross Profit | 196.4 Million | 177.35 Million | 177.56 Million | 154.32 Million | 642.49 Million | 179.61 Million |
| Operating Expenses | 136.04 Million | 103.77 Million | 106.36 Million | 122.96 Million | 454.78 Million | 135.3 Million |
| Selling, General and Administrative Expenses | 240.87 Million | 1.33 Million | 89.26 Million | -64.44 Million | - | 196.04 Million |
| Research and Development Expenses | 19.5 Million | 17.61 Million | 19.53 Million | 28.12 Million | - | 15.13 Million |
| Other Expenses | -124.33 Million | -46.46 Million | 35.99 Thousand | -73.64 Million | -73.97 Million | -318.29 Thousand |
| Cost and Expenses | 531.16 Million | 472.7 Million | 448.24 Million | 572.92 Million | 1.98 Billion | 493.06 Million |
| Operating Income | 24.35 Million | 50.99 Million | 49.98 Million | -14.38 Million | 104.73 Million | 21.09 Million |
| Interest Expense | 64.3 Million | - | 18.78 Million | -52.01 Million | -9.07 Million | 14.86 Million |
| Income Tax Expense | 1.66 Million | 7.03 Million | 2.45 Million | 2.13 Million | 7.06 Million | 2.59 Million |
| Earnings before Tax | 24.13 Million | 50.05 Million | 50.02 Million | -17.29 Million | 101.49 Million | 20.77 Million |
| Net Income | 22.74 Million | 45.87 Million | 45.14 Million | -16.6 Million | 86.45 Million | 13.7 Million |
| Earnings Per Share Basic | 0.03 | 0.06 | 0.06 | -0.02 | - | 0.02 |
| Earnings Per Share Diluted | 0.03 | 0.06 | 0.06 | -0.02 | - | 0.02 |
| Weighted Average Shares Outstanding | 749.32 Million | 781.02 Million | 781.02 Million | 780.66 Million | 780.29 Million | 753.75 Million |
| Weighted Average Shares Outstanding (Diluted) | 749.32 Million | 781.02 Million | 781.02 Million | 780.66 Million | 780.29 Million | 753.75 Million |
| Gross Margin | 0.33 | 0.32 | 0.34 | 0.26 | 0.30 | 0.33 |
| EBIT Margin | 0.15 | 0.06 | 0.14 | -0.08 | - | 0.07 |
| Profit Margin | 0.04 | 0.08 | 0.09 | -0.03 | 0.04 | 0.03 |
| EBITDA | 88.43 Million | 32.01 Million | 74.12 Million | -47.39 Million | - | 39.85 Million |
| Earnings Before Tax Margin | 0.04 | 0.09 | 0.10 | -0.02 | 0.05 | 0.04 |
KUMPFIN
JZCP
IMTL
300421
MLNOV
KREBSBIO